Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-17
2006-01-17
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S125000, C548S131000, C548S136000, C548S195000, C548S215000, C548S245000, C548S255000, C548S262200, C548S300100, C548S364700, C548S465000, C546S139000, C546S152000, C546S159000, C544S180000, C544S182000, C514S415000
Reexamination Certificate
active
06987122
ABSTRACT:
2-(1H-Indol-3-yl)-2-oxo-acetamide derivatives of formula (I) having antitumor activity in particular against solid tumors, specifically colon and lung tumors.
REFERENCES:
patent: 6232327 (2001-05-01), Nickel et al.
patent: 6693119 (2004-02-01), Nickel et al.
patent: 6753342 (2004-06-01), Menta et al.
patent: 0 490 263 (1992-06-01), None
patent: WO 99 51224 (1999-10-01), None
patent: WO 99 55696 (1999-11-01), None
patent: WO 00 67802 (2000-11-01), None
patent: WO 01 47916 (2001-07-01), None
Polymeropoulos, E. E., et al., “A Peptide Binding Site Model for PDE 4 Inhibitors”,Quant. Struct.-Act. Relat., vol. 18, No. 6 (1999) pp. 543-547.
Menta Ernesto
Pescalli Nicoletta
Novuspharma S.p.A.
Rothwell Figg Ernst & Manbeck P.C.
Shameem Golam M. M.
LandOfFree
2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3557166